Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 1, 2008, Pages 24-31

  Tao, Xia ^a   Zhang, Ya Jun ^a   Shen, Fu Ming ^a   Guan, Yun Feng ^a   Su, Ding Feng ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fosinopril; Phosphodiesterases; Pulmonary artery; Sinoaortic denervation; Vascular remodeling

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOSINOPRIL; PHENYLEPHRINE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE V;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA SINUS; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL WALL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME REGULATION; HEART DENERVATION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG MODEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BLOOD PRESSURE; CYCLIC GMP; DENERVATION; FOSINOPRIL; GENE EXPRESSION REGULATION; MALE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORIC DIESTER HYDROLASES; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 38349130250     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318159e097     Document Type: Article

References (48)

1. Jordan J, Tank J, Shannon JR, et al. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation. 2002;105:1459-1464.
2. Sturrock A, Cahill B, Norman K, et al. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006;290:L661-L673
3. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci. 2005;26:388-390.
4. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol. 2001;28:709-715.
5. Schreihofer AM, Sved AF. Use of sinoaortic denervation to study the role of baroreceptors in cardiovascular regulation. Am J Physiol. 1994;266:R1705-1710.
6. Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension. 2002;39:710-714.
7. Tao X, Zhang SH, Chu ZX, et al. Apoptosis is involved in the cardiac damage induced by sinoaortic denervation in rats. Clin Exp Pharmacol Physiol. 2003;30:362-368.
8. Tao X, Zhang SH, Shen FM, et al. High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats. J Hypertens. 2004;22:557-563.
9. Shen FM, Zhang SH, Xie HH, et al. Early structural changes of aortic wall in sinoaortic-denervated rats. Clin Exp Pharmacol Physiol. 2006;33:358-363.
10. Miao CY, Cai GJ, Tao X, et al. Greater hypertrophy in right than left ventricles is associated with pulmonary vasculopathy in sinoaortic-denervated Wistar-Kyoto rats. Clin Exp Pharmacol Physiol. 2004;31:450-455.
11. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89-144.
12. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol. 2006;168:659-669.
13. Mandegar M, Fung YC, Huang W, et al. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res. 2004;68:75-103.
14. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675-691.
15. Ferrari AU, Radaelli A, Mori T, et al. Nitric oxide-dependent vasodilation and the regulation of arterial blood pressure. J Cardiovasc Pharmacol. 2001;38(Suppl 2):S19-22.
16. Kenney MJ, Weiss ML, Mendes T, et al. Role of paraventricular nucleus in regulation of sympathetic nerve frequency components. Am J Physiol Heart Circ Physiol. 2003;284:H1710-H1720.
17. Campese VM, Ye S, Zhong H, et al. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol. 2004;287:H695-H703.
18. Miao CY, Zhang LM, Yuan WJ, et al. Angiotensin II and AT1 receptor in hypertrophied ventricles and aortas of sinoaortic-denervated rats. Acta Pharmacol Sin. 2003;24:812-818.
19. Barrett CJ, Guild SJ, Ramchandra R, et al. Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension. 2005;46:168-172.
20. Petersen JS, Hinojosa-Laborde C, DiBona GF. Sympathoinhibitory responses to 2-methylserotonin during changes in sodium intake. Hypertension. 1993;21:1000-1004.
21. Veelken R, Sawin LL, DiBona GF. Epicardial serotonin receptors in circulatory control in conscious Sprague-Dawley rats. Am J Physiol. 1990;258:H466-H472.
22. Murray F, Patel HH, Suda RY, et al. Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1. Am J Physiol Lung Cell Mol Physiol. 2007;292:L294-303.
23. Koyama H, Bornfeldt KE, Fukumoto S, et al. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation. J Cell Physiol. 2001;186:1-10.
24. Evgenov OV, Busch CJ, Evgenov NV, et al. Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2006;290:L723-L729.
25. Schermuly RT, Pullamsetti SS, Kwapiszewska G, et al. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reversere-modeling therapy. Circulation. 2007;115:2331-2339.
26. Phillips PG, Long L, Wilkins MR, et al. cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 2005;288:L103-115.
27. Xiang RP, Sun WD, Zhang KC, et al. Sodium chloride-induced acute and chronic pulmonary hypertension syndrome in broiler chickens. Poult Sci. 2004;83:732-736.
28. Borghi C, Marino P, Zardini P, et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. Am Heart J. 1998;136:213-225.
29. Shen FM, Su DF. The effect of adenosine on blood pressure variability in sinoaortic denervated rats is mediated by adenosine A2a-Receptor. J Cardiovasc Pharmacol. 2000;36:681-686.
30. Su DF, Cerutti C, Barres C, et al. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Physiol. 1986;251:H1111-1117.
31. Su DF, Xu LP, Miao CY, et al. Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats. Acta Pharmacol Sin. 2004;25:148-151.
32. Han P, Chu ZX, Shen FM, et al. Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats. Acta Pharmacol Sin. 2006;27:1575-1579.
33. Hongfang J, Cong B, Zhao B, et al. Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sci. 2006;78:1299-1309.
34. Henrion D, Dowell FJ, Levy BI, et al. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension. 1996;28:361-366.
35. Sauzeau V, Rolli-Derkinderen M, Lehoux S, et al. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Circ Res. 2003;93:630-637.
36. d'Uscio LV, Milstien S, Richardson D, et al. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res. 2003;92:88-95.
37. Geiss GK, An MC, Bumgarner RE, et al. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and - independent events. J Virol. 2001;75:4321-4331.
38. Rose F, Grimminger F, Appel J, et al. Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. Faseb J. 2002;16:1660-1661.
39. Ben Driss A, Devaux C, Henrion D, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation. 2000;101:2764-2770.
40. Rybalkin SD, Bornfeldt KE, Sonnenburg WK, et al. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. J Clin Invest. 1997;100:2611-2621.
41. Kim D, Rybalkin SD, Pi X, et al. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation. 2001;104:2338-2343.
42. Miao CY, Tao X, Gong K, et al. Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol. 2001;37:6-15.
43. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol. 2003;285:C499-508.
44. Lam CF, Peterson TE, Croatt AJ, et al. Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2005;289:H2334-2341.
45. Nava E, Farre AL, Moreno C, et al. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J Hypertens. 1998;16:609-615.
46. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension. 1998;31:1248-1254.
47. Rizzoni D, Castellano M, Porteri E, et al. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Am J Hypertens. 1997;10:1034-1043.
48. Borghi C, Marino P, Zardini P, et al. Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS). Am J Hypertens. 1997;10:247S-254S.